Table 2: Hemoglobin before sample collection and hematological parameters of study participants by duration of stay prior to transfusion (Mean ± SEM).
Characteristic |
N |
Hb (g/dl) |
WBC (109/L) |
LYMT (109/L) |
MID (109/L) |
GRAN (109/L) |
RBC (1012/) |
Hb (g/dL) |
HCT (%) |
MCV (fL) |
MCH (pg) |
Duration (Baseline) |
52
|
13.84 ± 0.147
|
4.08 ± 0.278a
|
2.68 ± 0.179a
|
0.41 ± 0.064ab
|
0.96 ± 0.068a
|
2.39 ± 0.154
|
7.54 ± 0.523
|
22.79 ± 1.570a
|
84.61 ± 0.667a
|
28.87 ± 0.325abc
|
7
|
52
|
13.84 ± 0.147
|
3.00 ± 0.339b
|
2.43 ± 0.284ab
|
0.27 ± 0.034bc
|
0.31 ± 0.068b
|
2.89 ± 0.210
|
7.92 ± 0.558
|
24.18 ± 1.725a
|
84.99 ± 0.742a
|
28.26 ± 0.291c
|
14
|
52
|
13.84 ± 0.147
|
1.83 ± 0.104c
|
1.74 ± 0.219bc
|
0.46 ± 0.076a
|
0.16 ± 0.068b
|
2.75 ± 0.171
|
7.62 ± 0.530
|
23.11 ± 1.603a
|
80.18 ± 0.756b
|
28.76 ± 0.285bc
|
21
|
52
|
13.84 ± 0.147
|
0.83 ± 0.053d
|
1.27 ± 0.111cd
|
0.21 ± 0.037c
|
0.20 ± 0.068b
|
2.50 ± 0.180
|
7.46 ± 0.549
|
24.71 ± 1.822a
|
75.63 ± 0.669c
|
29.70 ± 0.339 ab
|
28
|
52
|
13.84 ± 0.147
|
0.83 ± 0.053d
|
097 ± 0.041d
|
0.09 ± 0.004c
|
0.06 ± 0.068b
|
2.38 ± 0.168
|
7.28 ± 0.532
|
26.77 ± 1.397b
|
77.53 ± 0.669bc
|
30.07 ± 0.316 a
|
35 |
52
|
13.84 ± 0.147 |
0.92 ± 0.062d |
0.74 ± 0.054d |
0.10 ± 0.000c |
0.06 ± 0.068b |
2.42 ± 0.169 |
7.03 ± 0.495 |
23.46 ± 1.689a |
75.29 ± 0.669c |
29.44 ± 0.314abc |
F-Ratio |
|
0.000 |
52.148 |
20.905 |
11.619 |
25.336 |
1.486 |
0.3223 |
3.103 |
38.406 |
4.609 |
P-value |
|
1.000 |
< 0.0001**** |
< 0.0001**** |
< 0.0001**** |
< 0.0001**** |
0.1941 |
0.8994 |
0.0095** |
< 0.0001**** |
0.0005*** |
Significance Level: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001